Literature DB >> 5286084

Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).

P H Wiernik, A A Serpick.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5286084     DOI： 10.1097/00005792-197011000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  10 in total

1.  Effect of body mass index on the outcome of children with acute myeloid leukemia.

Authors:  Hiroto Inaba; Harriet C Surprise; Stanley Pounds; Xueyuan Cao; Scott C Howard; Karen Ringwald-Smith; Jassada Buaboonnam; Gary Dahl; W Paul Bowman; Jeffrey W Taub; Dario Campana; Ching-Hon Pui; Raul C Ribeiro; Jeffrey E Rubnitz
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

2.  Prolonged remission maintenance in acute myeloid leukaemia.

Authors:  A S Spiers; J M Goldman; D Catovsky; C Costello; D A Galton; C S Pitcher
Journal:  Br Med J       Date:  1977-08-27

3.  Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.

Authors:  J L Poth; P K Johnson; R P George; S L Schrier
Journal:  Calif Med       Date:  1972-12

4.  Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.

Authors:  C B Freeman; R Harris; C G Geary; M J Leyland; J E MaCiver; I W Delamore
Journal:  Br Med J       Date:  1973-12-08

5.  Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.

Authors:  B Lönnqvist; B Andersson; M Björkholm; L Engstedt; G Gahrton; R Hast; G Holm; A Killander; B Lantz; D Lockner; H Mellstedt; J Palmblad; C Paul; C Peterson; B Simonsson; A M Stalfelt; A M Udén; B Wadman; G Oberg
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance.

Authors:  D J Hentges; A J Stein; S W Casey; J U Que
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

7.  Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome.

Authors:  Antonio Ruggiero; G Attinà; M Piastra; P Maurizi; S Mastrangelo; D Pietrini; R Riccardi
Journal:  Int J Hematol       Date:  2009-05-23       Impact factor: 2.490

8.  Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.

Authors:  R Harris; S R Zuhrie; C B Freeman; G M Taylor; J E MacIver; C G Geary; I W Delamore; P J Hull; J A Tooth
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

Review 9.  The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia.

Authors:  Xia Sheng; Steven D Mittelman
Journal:  Front Pediatr       Date:  2014-06-05       Impact factor: 3.418

10.  Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia.

Authors:  Peter H Wiernik; Zhuoxin Sun; Larry D Cripe; Jacob M Rowe; Hugo F Fernandez; Selina M Luger; Hillard M Lazarus; Elisabeth M Paietta; Martin S Tallman; Mark R Litzow
Journal:  Br J Haematol       Date:  2021-06-17       Impact factor: 8.615
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.